Aberrant cutaneous expression of the angiogenic factor midkine is associated with neurofibromatosis type-1.

Neurofibromatosis type 1 is a common autosomal dominant disorder (incidence 1:3500) characterized by lesions that include neural crest derivatives such as Schwann cells and melanocytes. A critical event in the pathogenesis of neurofibromatosis type 1 is the heterozygous germ-line loss of the tumor suppressor gene NF1. Additional genetic and/or epigenetic events have been posited, including various alterations in growth factor expression. By in situ hybridization and immunohistochemistry, we demonstrate aberrant expression of the angiogenic and tumorigenic growth factor midkine in the skin of patients with neurofibromatosis type 1, but not normal individuals. We demonstrate that midkine expression is independent of the presence of neurofibromas, and thus appears to be associated with mutations in the NF1 gene. Furthermore, midkine-containing culture media is shown to stimulate the growth of human endothelial and neurofibroma-derived cells. In conclusion, we introduce the skin as a source of dysregulated growth factors in neurofibromatosis type 1, and suggest the further study of the angiogenic factor midkine in neurofibromatosis type 1 pathogenesis.

[1]  J. Arbiser,et al.  Analysis of vascularity of human neurofibromas. , 1998, Journal of the American Academy of Dermatology.

[2]  G. Michalopoulos,et al.  Hepatocyte growth factor and c-MET in benign and malignant peripheral nerve sheath tumors. , 1997, Human pathology.

[3]  T. Nishikawa,et al.  Expression of the retinoid-inducible polypeptide, midkine, in human epidermal keratinocytes , 1997, Archives of Dermatological Research.

[4]  T. Muramatsu,et al.  Stimulation of collagen expression and glycosaminoglycan synthesis by midkine in human skin fibroblasts , 1997, Archives of Dermatological Research.

[5]  S. Donnini,et al.  An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. , 1997, Cancer research.

[6]  T. Muramatsu,et al.  Midkine induces the transformation of NIH3T3 cells. , 1997, British Journal of Cancer.

[7]  D. Viskochil,et al.  Identification of NF1 mutations in both alleles of a dermal neurofibroma , 1996, Nature Genetics.

[8]  P. Bohlen,et al.  Transglutaminase forms midkine homodimers in cerebellar neurons and modulates the neurite-outgrowth response. , 1996, Biochemical and Biophysical Research Communications - BBRC.

[9]  A. Harris,et al.  The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. , 1996, Cancer research.

[10]  N. Copeland,et al.  Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons , 1995, Cell.

[11]  S. Peltonen,et al.  Neurofibromin: expression by normal human keratinocytes in vivo and in vitro and in epidermal malignancies. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[12]  A. Bernards,et al.  Neurofibromatosis type 1 and Ras-mediated signaling: filling in the GAPs. , 1995, Biochimica et biophysica acta.

[13]  J. Declue,et al.  Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes. , 1995, Oncogene.

[14]  J. Milbrandt,et al.  Differential expression of pleiotrophin and midkine in advanced neuroblastomas. , 1995, Cancer research.

[15]  I. Eisenbarth,et al.  Ras-GTP regulation is not altered in cultured melanocytes with reduced levels of neurofibromin derived from patients with neurofibromatosis 1 (NF1). , 1995, Biological chemistry Hoppe-Seyler.

[16]  A. Panoskaltsis-Mortari,et al.  In situ hybridization with digoxigenin-labeled RNA probes: facts and artifacts. , 1995, BioTechniques.

[17]  I. Thesleff,et al.  Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. , 1995, Development.

[18]  G. Michalopoulos,et al.  Hepatocyte growth factor is a mitogen for Schwann cells and is present in neurofibromas , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[19]  M. Tohyama,et al.  Localization of pleiotrophin and midkine in the postnatal developing cerebellum , 1994, Neuroscience Letters.

[20]  M. Wick,et al.  Midkine and pleiotrophin expression in normal and malignant breast tissue , 1994, Cancer.

[21]  N. Ratner,et al.  Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin. , 1994, The Journal of investigative dermatology.

[22]  F. Collins,et al.  Specific expression of the neurofibromatosis type 1 gene (NF1) in the hamster Schwann cell. , 1994, The American journal of pathology.

[23]  J. Fletcher,et al.  Role for the stem cell factor/KIT complex in schwann cell neoplasia and mast cell proliferation associated with neurofibromatosis , 1994, Journal of neuroscience research.

[24]  K. Takehara,et al.  The growth regulation of neurofibroma cells in neurofibromatosis type-1: increased responses to PDGF-BB and TGF-beta 1. , 1994, Biochemical and biophysical research communications.

[25]  Johannes Gerdes,et al.  Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sections , 1993, The Journal of pathology.

[26]  H. Asada,et al.  Possible involvement of c-kit receptor and its ligand in increase of mast cells in neurofibroma tissues. , 1993, Archives of pathology & laboratory medicine.

[27]  T. Muramatsu,et al.  Midkine, a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution. , 1993, Developmental biology.

[28]  A. Wellstein,et al.  Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer. , 1992, The Journal of biological chemistry.

[29]  T. Muramatsu,et al.  A new family of heparin binding growth/differentiation factors: differential expression of the midkine (MK) and HB-GAM genes during mouse development. , 1992, Journal of biochemistry.

[30]  D. Lowy,et al.  Identification and characterization of the neurofibromatosis type 1 protein product. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  F. Collins,et al.  Identification of the neurofibromatosis type 1 gene product. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[32]  K. Nakanishi,et al.  von Recklinghausen neurofibroma produces neuronal and glial growth-modulating factors , 1991, Brain Research.

[33]  R. Huang,et al.  A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis , 1990, The Journal of cell biology.

[34]  H. Hansson,et al.  Somatomedin C as tentative pathogenic factor in neurofibromatosis. , 1988, Scandinavian journal of plastic and reconstructive surgery and hand surgery.

[35]  M. Lebwohl,et al.  Nerve growth factor receptors on dissociated neurofibroma Schwann-like cells. , 1986, Cancer research.

[36]  V. M. Riccardi,et al.  Von Recklinghausen neurofibromatosis. , 1981, The New England journal of medicine.

[37]  G. Todaro,et al.  Increased serum levels of nerve growth factor in von Recklinghausen's disease. , 1981, Archives of neurology.